Latest Product News
3Brain AG CorePlate™ Technology Combines Microchips and AI in a New Approach to Drug Discovery
3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials.
Taking the Strain Out of Microplate Sealing
Porvair Sciences has announced its next-generation AutoCapper electronic sealer - a versatile device designed to take the strain out of applying friction sealing caps to a wide range of microplates.
Iksuda Therapeutics Closes $47 Million Financing Round
Iksuda Therapeutics, the developer of a new generation of antibody drug conjugates with raised therapeutic index, has announced it has completed a US $47 million financing round.
Corning Life Sciences Launches 3D Liver Kits
Corning Incorporated has announced the launch of its HepGo™ Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 pre-plated primary human hepatocyte spheroids in a single-spheroid microplate and HepGo Hepatocyte companion cell culture media.
Foresight Diagnostics Completes Series A Financing To Accelerate Minimal Residual Disease Technology
Foresight Diagnostics has announced the close of its $12.5M Series A financing to commercialize the minimal residual disease (MRD) detection assay.
Cmed Technology Adds More Capabilities to its Encapsia Platform
Cmed Technology has announced increased capabilities for encapsia, its advanced enterprise, cloud-based clinical data system, after increased demand for its use in decentralized trials.
Cytel Calls for Statistical Innovation to be Mobilized for Global Health Challenges
Cytel’s biostatisticians have evaluated the difficulties of conducting randomized control trials in low- and middle-income countries, and have revealed the power of new, innovative statistical methods to overcome the most pressing challenges in global health research.
GammaDelta Therapeutics Receives FDA Clearance For Novel Cell Cancer Therapy
GammaDelta Therapeutics has announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy,
Optibrium and BioPharmics Enter Partnership on Computational Drug Design
Optibrium Ltd and BioPharmics LLC, providers of software and computational solutions for drug discovery, have announced their partnership.
Sinocompound Sponsors Catalysis in the Fine Chemical Industry Conference
Sinocompound Catalysts Co., Ltd is sponsoring the upcoming Catalysis in the Fine Chemical Industry Conference.